Countermeasures in the early stages can prevent manifest rheumatoid arthritis

It would be a dream: to identify patients in the early stages of rheumatoid arthritis (pre-RA) and to prevent the manifestation of the disease through efficient countermeasures. Is this also realistic? At a symposium during the European League Against Rheumatism (EULAR) Congress in Madrid in June 2017, opportunities in different risk groups were discussed.